Medicaid Databases

Pharmacoepidemiology, Fourth Edition

Volumn , Issue , 2007, Pages 281-294

  Hennessy, Sean ^a   Carson, Jeffrey L ^b   Ray, Wayne A ^c   Strom, Brian L ^a,d,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CMS and Medicaid data; Diagnoses in Medicaid and ICD 9 CM coding scheme; Inpatient file on hospitalizations; Medicaid and non Medicaid populations; Medicaid databases; Medicaid encounter data; Medicaid program; National Drug Code (NDC); Personal Summary file and Long Term Care file

Indexed keywords

EID: 84889374872     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470059876.ch18     Document Type: Chapter

References (43)

1. A Profile of Medicaid. Washington, DC: US Department of Health and Human Services, 2000.
2. Pharmaceutical Benefits under State Medical Assistance Programs. Reston, VA: National Pharmaceutical Council, 2003.
3. Iglehart JK. The dilemma of Medicaid. N Engl J Med 2003; 348: 2140-8.
4. Menzin J, Boulanger L, Friedman M, Mackell J, Lloyd JR. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatr Serv 2003; 54: 719-23.
5. Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R et al. Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry 2002; 59:1147-54.
6. Laine C, Zhang D, Hauck WW, Turner BJ. HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: relationship with outpatient care patterns. J Acquir Immune Defic Syndr 2002; 29: 270-4.
7. Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004; 75: 234-41.
8. Farris KB, Kaplan B, Kirking DM. Examination of days supply in computerized prescription claims. J Pharmacoepidemiol 1994; 3: 63-76.
9. Wang PS, Levin R, Zhao SZ, Avorn J. Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients. J Am Geriatr Soc 2002; 50: 117-24.
10. Hennessy S, Bilker WB, Weber A, Strom BL. Descriptive analyses of the integrity of a US Medicaid claims database. Pharmacoepidemiol Drug Saf 2003; 12: 103-11.
11. Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002; 325: 1070.
12. Staffa JA, Jones JK, Gable CB, Verspeelt JP, Amery WK. Risk of selected serious cardiac events among new users of antihistamines. Clin Ther 1995; 17: 1062-77.
13. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58: 1161-7.
14. Ray WA, Gigante J, Mitchel EF Jr, Hickson GB. Perinatal outcomes following implementation of TennCare. JAMA 1998; 279: 314-16.
15. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136: 873-83.
16. Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R et al. Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry 2002; 59: 1147-54.
17. Lessler JT, Harris BSH. Medicaid Data as a Source for Postmarketing Surveillance Information. Research Triangle Park, NC: Research Triangle Institute, 1984.
18. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37: 846-57.
19. Wysowski DK, Baum C. The validity of Medicaid diagnoses of hip fracture. Am J Public Health 1993; 83: 770.
20. Thapa PB, Whitlock JA, Brockman Worrell KG, Gideon P, Mitchel EF, Jr., Roberson P et al. Prenatal exposure to metronidazole and risk of childhood cancer: a retrospective cohort study of children younger than 5 years. Cancer 1998; 83: 1461-8.
21. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitorassociated angioedema. Clin Pharmacol Ther 1996; 60: 8-13.
22. National Hospital Discharge Survey 2001. Hyattsville, MD: National Center for Health Statistics, 2003.
23. Henry D, Lim LL, Garcia Rodriguez LA, Perez GS, Carson JL, Griffin M et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996; 312: 1563-6.
24. Strom BL, Carson JL, Morse ML, West SL, Soper KA. The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal antiinflammatory drugs. Arthritis Rheum 1987; 30: 1142-8.
25. Carson JL, Strom BL, Duff A, Gupta A, Das K. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. Arch Intern Med 1993; 153: 1331-6.
26. Carson JL, Strom BL, Duff A, Gupta A, Shaw M, Das K. The feasibility of studying drug-induced acute hepatitis with use of Medicaid data. Clin Pharmacol Ther 1992; 52: 214-19.
27. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989; 129: 837-49.
28. Griffin MR, Ray WA, Schaffner W. Nonsteroidal antiinflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359-63.
29. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262: 3303-7.
30. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144-53.
31. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M. Descriptive epidemiology of agranulocytosis. Arch Intern Med 1992; 152: 1475-80.
32. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 1991; 127: 831-8.
33. Avorn J, Gurwitz JH, Bohn RL, Mogun H, Monane M, Walker A. Increased incidence of levodopa therapy following metoclopramide use. JAMA 1995; 274: 1780-2.
34. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1998.
35. Ray WA, Griffin MR, Downey W, Melton LJ3d. Long-term use of thiazide diuretics and risk of hip fracture. Lancet 1989; 1: 687-90.
36. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987; 147: 85-8.
37. Carson JL, Strom BL, Schinnar R, Duff A, Sim E. The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids. Am J Med 1991; 91: 223-8.
38. Carson JL, Strom BL, Duff A, Gupta A, Shaw M, Lundin FE et al. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Intern Med 1993; 119: 576-83.
39. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Lundin FE Jr. Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med 1993; 153: 2119-24.
40. McKenzie DA, Semradek J, McFarland BH, Mullooly JP, McCamant LE. The validity of Medicaid pharmacy claims for estimating drug use among elderly nursing home residents: the Oregon experience. J Clin Epidemiol 2000; 53: 1248-57.
41. dosReis S, Zito JM, Buchanan RW, Lehman AF. Antipsychotic dosing and concurrent psychotropic treatments for Medicaidinsured individuals with schizophrenia. Schizophr Bull 2002; 28: 607-17.
42. McCombs JS, Shi L, Croghan TW, Stimmel GL. Access to drug therapy and substitution between alternative antidepressants following an expansion of the California Medicaid formulary. Health Policy 2003; 65: 301-11.
43. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994; 331: 650-5.